tirzepatide patent expiry india π India's Pharma Innovation Shift: From Cost Leader to Value Creator The numbers tell a compelling story: 40+ Indian pharma companies launching 50+ semaglutide brands post-patent (March 20, 2026). But here's India GLP-1 Receptor Agonist Market
Pay in 4 interest-free payments of $6.06 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours Β· Estimated delivery Aug 11 - Aug 16

)







:max_bytes(150000):strip_icc()/health-GettyImages-1340013135-64ee8863eb944cb2a0c308eee92f5bd2.jpg)














